Quantification of Immunoglobulin G against Trypanosoma cruzi in Individuals with Chronic Chagas Disease Treated with Nifurtimox and Evaluated in Prolonged Follow-Up

Korean J Parasitol. 2019 Feb;57(1):39-41. doi: 10.3347/kjp.2019.57.1.39. Epub 2019 Feb 26.

Abstract

In the indeterminate chronic period of Chagas disease (ChD) the treatment has not been conclusive, because the serological negativization requires many years. This study aims to evaluate the efficacy of nifurtimox (NF) in the treatment of chronic ChD in prolonged follow-up by serological techniques of indirect immunofluorescence assay (IFA) and enzyme-linked immunosorbent assay (ELISA) IgG comparing 2 groups of patients, treated and non treated. Mann-Whitney test was performed for ELISA and IFA, with significant difference between the groups (P < 0.05). IgG levels were lower in individuals treated compared with untreated patients, indicating chemotherapeutic efficacy in prolonged follow-up.

Keywords: ELISA; IFA; IgG; chronic Chagas disease; follow-up; nifurtimox.

MeSH terms

  • Antibodies, Protozoan / blood*
  • Chagas Disease / drug therapy*
  • Chagas Disease / immunology*
  • Chronic Disease
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Fluorescent Antibody Technique, Indirect
  • Follow-Up Studies
  • Humans
  • Immunoglobulin G / blood*
  • Male
  • Middle Aged
  • Nifurtimox / administration & dosage*
  • Treatment Outcome
  • Trypanocidal Agents / administration & dosage*
  • Trypanosoma cruzi / immunology*

Substances

  • Antibodies, Protozoan
  • Immunoglobulin G
  • Trypanocidal Agents
  • Nifurtimox